Bruker (BRKR) vs EyePoint (EYPT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bruker (BRKR) has outperformed EyePoint (EYPT) over the past year, gaining 72.8% versus a loss of 74.9%. Over five years, BRKR leads with a -22.7% price change compared with -71.0% for EYPT. Bruker is the larger company by market cap ($8.80 billion vs $282.1 million), about 31.2 times the size.
Bruker pays a dividend yielding 0.35%, while EyePoint does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRKR | EYPT |
|---|---|---|
| Share price | $57.74 | $3.37 |
| Market cap | $8.80B | $282.13M |
| 1-day change | -3.32% | +1.36% |
| YTD return | +26.77% | -81.83% |
| 1-year return | +72.80% | -74.94% |
| 5-year return | -22.67% | -70.98% |
| Forward P/E | 23.93 | — |
| EPS (TTM) | $-0.70 | $-3.75 |
| Dividend yield | 0.35% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | $3.44B | — |
| Revenue growth (YoY) | +2.08% | — |
| Net income (latest FY) | $-8.60M | — |
| Gross margin | 45.91% | — |
| Operating margin | 1.98% | — |
| Net margin | -0.25% | — |
| 52-week high | $66.98 | $19.11 |
| 52-week low | $32.37 | $3.05 |
| Distance from 52-week high | -13.80% | -82.39% |
| Analyst consensus | buy | none |
| Avg. price target upside | +9.55% | +669.99% |
| Average volume | 2.23M | 3.93M |
| Shares outstanding | 152.36M | 83.84M |
| Employees | 11,085 | 214 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bruker is about 31.2 times larger than EyePoint by market value ($8.80B vs $282.13M).
- BRKR has outperformed EYPT by 147.7 percentage points over the past year.
About Bruker
BRKR stock →Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,085 employees
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees
BRKR vs EYPT FAQ
Which is bigger, Bruker or EyePoint?
Bruker (BRKR) is larger, with a market capitalization of $8.80B compared with $282.13M for EyePoint (EYPT).
Which stock has performed better over the past year, BRKR or EYPT?
BRKR returned +72.80% over the past 12 months, compared with -74.94% for EYPT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Bruker or EyePoint?
Bruker pays a dividend yielding 0.35%, while EyePoint does not currently pay a regular dividend.
Are Bruker and EyePoint in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.